Amylyx Pharmaceuticals, Inc. (AMLX) Tops Q1 EPS by 20c

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q1 EPS of ($0.42), $0.20 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.

You May Also Be Interested In

• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• William Blair Upgrades Backblaze Inc (BLZE) to Market Perform
• Tenable Holdings, Inc. (TENB) call put ratio 80 calls to 1 put with a focus on 200 contracts of July 32 calls as share price up 5.6%